Wells Fargo Revises Abbott Laboratories Price Target Amid Nutrition Division Challenges
Wells Fargo has trimmed its price objective for Abbott Laboratories to $122 from $146 while reiterating an Overweight rating. The revision follows Abbott's fourth-quarter earnings release showing a revenue shortfall attributed primarily to the Nutrition segment alongside other temporary setbacks. Despite these challenges, the company’s earnings per…